Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001397882 | SCV001599643 | likely benign | Telangiectasia, hereditary hemorrhagic, type 5 | 2024-11-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003169130 | SCV003911975 | likely benign | Cardiovascular phenotype | 2022-11-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001397882 | SCV004565321 | likely benign | Telangiectasia, hereditary hemorrhagic, type 5 | 2023-08-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003918382 | SCV004742593 | likely benign | GDF2-related disorder | 2019-05-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |